PAG
ADPT icon

Private Advisor Group’s Adaptive Biotechnologies ADPT Stock Holding History

Private Advisor Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$982K Buy
45,777
+1,800
+4% +$27.6K ﹤0.01% 1391
2026
Q1 		$610K Sell
43,977
-168
-0.4% -$2.68K ﹤0.01% 1728
2025
Q4 		$717K Hold
44,145
– – ﹤0.01% 1605
2025
Q3 		$660K Buy
44,145
+168
+0.4% +$2.05K ﹤0.01% 1620
2025
Q2 		$512K Hold
43,977
– – ﹤0.01% 1671
2025
Q1 		$327K Hold
43,977
– – ﹤0.01% 1822
2024
Q4 		$264K Buy
+43,977
New +$242K ﹤0.01% 1933

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Private Advisor Group's ADPT Position: Q2 2026 in Review

Private Advisor Group increased its Adaptive Biotechnologies (ADPT) stake by 4.1% in Q2 2026, buying an estimated $27.6K and bringing the position to 45,777 shares worth $982K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Private Advisor Group first reported a position in ADPT in Q4 2024 and has held it in 7 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Private Advisor Group held 45,777 shares of Adaptive Biotechnologies worth $982K as of Q2 2026.
  • Private Advisor Group bought 1,800 Adaptive Biotechnologies shares in Q2 2026, an estimated $27.6K.
  • Adaptive Biotechnologies made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1391 holding.
  • Private Advisor Group first reported a position in Adaptive Biotechnologies in Q4 2024 and has held it in 7 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.